Close
Help
Need Help?





JOURNAL

Clinical Medicine Insights: Pediatrics

183,040 Journal Article Views | Journal Analytics

Efficacy and Safety of Atomoxetine in the Treatment of Children and Adolescents with Attention Deficit Hyperactivity Disorder

Submit a Paper



Publication Date: 05 Nov 2012

Type: Review

Journal: Clinical Medicine Insights: Pediatrics

Citation: Clinical Medicine Insights: Pediatrics 2012:6 95-162

doi: 10.4137/CMPed.S7868

Abstract

Several non-stimulant medications have been used in the treatment of attention deficit hyperactivity disorder (ADHD). Atomoxetine, was introduced in 2002. The safety and efficacy of atomoxetine in the treatment of ADHD for children, adolescents, and adults has been evaluated in over 4000 patients in randomized controlled studies and double blinded studies as well as in recent large longitudinal studies. This paper provides an updated summary of the literature on atomoxetine, particularly in relation to findings on the short- and long-term safety of atomoxetine in children and adolescents arising from recent large longitudinal cohort studies. Information is presented about the efficacy, safety, and tolerability of this medication.


Downloads

PDF  (1.33 MB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)

XML

PMC HTML


Sharing




What Your Colleagues Say About Clinical Medicine Insights: Pediatrics
It has been a great experience publishing my work with Libertas Academia. The process from submission to publication was fast and transparent. I highly recommend Clinical Medicine Insights: Pediatrics to my colleagues.
Dr Frenny Sheth (Foundation for Research in Genetics and Endocrinology’s Institute of Human Genetics, FRIGE House, Ahmedabad, India)
More Testimonials

Quick Links


New article and journal news notification services
Email Alerts RSS Feeds
Facebook Google+ Twitter
Pinterest Tumblr YouTube